1. R.W. Sidwell, J.H. Huffman, G.P. Khare, L.B. Allen, J.T. Witkowski, and R.K. Robins, Science, 177 (1972) 705–706; J.T. Witkowski, R.K. Robins, R.W. Sidwell, and L.N. Simon, J. Med. Chem., 15 (1972) 1150–1154.
2. P.C. Srivastava, M.V. Pickering, L.B. Allen, D.G. Streeter, M.T. Campbell, J.T. Witkowski, R.W. Sidwell, and R.K. Robins, J. Med. Chem., 20 (1977) 256–262; P.C. Srivastava and R.K. Robins, J. Med. Chem., 26 (1983) 445–448; R.K. Robins, P.C. Srivastava, V.L. Narayanan, J. Powman, and K.D. Paull, J. Med. Chem., 25 (1982) 107–108; H.N. Jayaram, A.L. Smith, R.I. Glazer, D.G. Johns, and D.A. Cooney, Biochem. Pharmacol., 31 (1982) 3839–3845; W. Zhen, H.N. Jayaram, and G. Weber, Cancer Invest., 10 (1992) 505–511; H.N. Jayaram, G.S. Ahluwalia, R.L. Dion, G. Gebeyehu, V.E. Marquez, J.A. Kelley, R.K. Robins, D.A. Cooney, and D.G. Johns, Biochem. Pharmacol., 32 (1983) 2633–2636; B.M. Goldstein, J.F. Leary, B.A. Farley, V.E. Marquez, and P.T. Rowley, Blood, 78 (1991) 593–598; Z. Parandoosh, B. Rubalcava, S.S. Matsumoto, W.B. Jolley, and R.K. Robins, Life Sci., 46 (1990) 315–329; S.M. Kharbanda, M.L. Sherman, D.R. Springs, and D.W. Kufe, Cancer Res., 48 (1988) 5965–5968.
3. D.A. Cooney, H.N. Jayaram, G. Gebeyehu, C.R. Betts, J.A. Kelley, V.E. Marquez, and D.G. Johns, Biochem. Pharmacol., 31 (1982) 2133–2136; H.N. Jayaram, R.L. Dion, R.I. Glazer, D.G. Johns, R.K. Robins, P.C. Srivastava, and D.A. Cooney, Biochem. Pharmacol., 31 (1982) 2371–2380; R. Kuttan, R.K. Robins, and P.P. Saunders, Biochem. Biophys. Res. Commun., 107 (1982) 862–868.
4. I. Maeba, Y. Ito, M. Wakimura, and C. Ito, Heterocycles, 36 (1993) 1617–1623.
5. I. Maeba, Y. Nishiyama, S. Kanazawa, and A. Sato, Heterocycles, 41 (1995) 507–513.